# RB Global Inc.: financial statements, quarterly

RBA · NYSE · CIK 1046102 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rba.md) · [Financials](/companies/rba/financials.md) · [Filings](/companies/rba/filings.md) · [Insiders](/companies/rba/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rba/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,020](/filings/0001628280-24-046505.md) | [1,041 d](/filings/0001628280-26-011682.md) | [1,065](/filings/0001628280-25-023159.md) | [1,096](/filings/0001628280-25-038323.md) | [982](/filings/0001046102-25-000009.md) | [1,142 d](/filings/0001628280-26-011682.md) | [1,109](/filings/0001628280-26-029808.md) | [1,186](/filings/0001628280-26-052582.md) | [1,093](/filings/0001046102-25-000009.md) | [1,203 d](/filings/0001628280-26-011682.md) | [1,235](/filings/0001628280-26-029808.md) | [1,317](/filings/0001628280-26-052582.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [204](/filings/0001628280-24-046505.md) | [198 d](/filings/0001628280-26-011682.md) | [198](/filings/0001628280-25-023159.md) | [209](/filings/0001628280-25-038323.md) | [178](/filings/0001046102-25-000009.md) | [189 d](/filings/0001628280-26-011682.md) | [205](/filings/0001628280-26-029808.md) | [222](/filings/0001628280-26-052582.md) | [218](/filings/0001046102-25-000009.md) | [260 d](/filings/0001628280-26-011682.md) | [214](/filings/0001628280-26-029808.md) | [211](/filings/0001628280-26-052582.md) |
| Operating income | $m | [146](/filings/0001628280-24-046505.md) | [171 d](/filings/0001628280-26-011682.md) | [199](/filings/0001628280-25-023159.md) | [202](/filings/0001628280-25-038323.md) | [153](/filings/0001046102-25-000009.md) | [207 d](/filings/0001628280-26-011682.md) | [190](/filings/0001628280-26-029808.md) | [189](/filings/0001628280-26-052582.md) | [158](/filings/0001046102-25-000009.md) | [177 d](/filings/0001628280-26-011682.md) | [218](/filings/0001628280-26-029808.md) | [225](/filings/0001628280-26-052582.md) |
| Interest expense | $m | [63.7](/filings/0001628280-23-038257.md) | [64.2 d](/filings/0001628280-24-007570.md) | [63.9](/filings/0001628280-24-022241.md) | [59.9](/filings/0001628280-24-034972.md) | [57.2](/filings/0001046102-25-000009.md) | [52.7 d](/filings/0001628280-26-011682.md) | [49.9](/filings/0001628280-26-029808.md) | [47.5](/filings/0001628280-26-052582.md) | [48.2](/filings/0001046102-25-000009.md) | [46.0 d](/filings/0001628280-26-011682.md) | [44.0](/filings/0001628280-26-029808.md) | [42.4](/filings/0001628280-26-052582.md) |
| Income tax | $m | [23.1](/filings/0001628280-24-046505.md) | [29.9 d](/filings/0001628280-26-011682.md) | [32.5](/filings/0001628280-25-023159.md) | [36.6](/filings/0001628280-25-038323.md) | [26.2](/filings/0001046102-25-000009.md) | [42.0 d](/filings/0001628280-26-011682.md) | [29.6](/filings/0001628280-26-029808.md) | [35.8](/filings/0001628280-26-052582.md) | [16.5](/filings/0001046102-25-000009.md) | [26.1 d](/filings/0001628280-26-011682.md) | [37.6](/filings/0001628280-26-029808.md) | [42.4](/filings/0001628280-26-052582.md) |
| Net income | $m | [63.4](/filings/0001628280-24-046505.md) | [84.3 d](/filings/0001628280-26-011682.md) | [107](/filings/0001628280-25-023159.md) | [111](/filings/0001628280-25-038323.md) | [76.1](/filings/0001046102-25-000009.md) | [119 d](/filings/0001628280-26-011682.md) | [113](/filings/0001628280-26-029808.md) | [110](/filings/0001628280-26-052582.md) | [95.5](/filings/0001046102-25-000009.md) | [110 d](/filings/0001628280-26-011682.md) | [136](/filings/0001628280-26-029808.md) | [144](/filings/0001628280-26-052582.md) |
| Diluted EPS | $ per share | [0.30](/filings/0001628280-24-046505.md) | not reported | [0.53](/filings/0001628280-25-023159.md) | [0.54](/filings/0001628280-25-038323.md) | [0.36](/filings/0001046102-25-000009.md) | not reported | [0.55](/filings/0001628280-26-029808.md) | [0.53](/filings/0001628280-26-052582.md) | [0.43](/filings/0001046102-25-000009.md) | not reported | [0.66](/filings/0001628280-26-029808.md) | [0.71](/filings/0001628280-26-052582.md) |
| Basic EPS | $ per share | [0.30](/filings/0001628280-24-046505.md) | not reported | [0.53](/filings/0001628280-25-023159.md) | [0.55](/filings/0001628280-25-038323.md) | [0.36](/filings/0001046102-25-000009.md) | not reported | [0.56](/filings/0001628280-26-029808.md) | [0.54](/filings/0001628280-26-052582.md) | [0.43](/filings/0001046102-25-000009.md) | not reported | [0.67](/filings/0001628280-26-029808.md) | [0.71](/filings/0001628280-26-052582.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001628280-23-038257.md) | [0.6](/filings/0001628280-25-008201.md) | [0.5](/filings/0001628280-24-022241.md) | [0.6](/filings/0001628280-24-034972.md) | [0.7](/filings/0001628280-24-046505.md) | [0.5](/filings/0001628280-26-011682.md) | [0.6](/filings/0001628280-25-023159.md) | [0.7](/filings/0001628280-25-038323.md) | [0.7](/filings/0001046102-25-000009.md) | [0.5](/filings/0001628280-26-052582.md) | [0.7](/filings/0001628280-26-029808.md) | [0.5](/filings/0001628280-26-052582.md) |
| Current assets | $bn | [1.8](/filings/0001628280-23-038257.md) | [1.8](/filings/0001628280-25-008201.md) | [1.9](/filings/0001628280-24-022241.md) | [2.0](/filings/0001628280-24-034972.md) | [1.9](/filings/0001628280-24-046505.md) | [1.7](/filings/0001628280-26-011682.md) | [1.8](/filings/0001628280-25-023159.md) | [1.9](/filings/0001628280-25-038323.md) | [1.9](/filings/0001046102-25-000009.md) | [1.8](/filings/0001628280-26-052582.md) | [2.1](/filings/0001628280-26-029808.md) | [1.9](/filings/0001628280-26-052582.md) |
| Total assets | $bn | [12.0](/filings/0001628280-23-038257.md) | [12.0](/filings/0001628280-25-008201.md) | [12.0](/filings/0001628280-24-022241.md) | [12.1](/filings/0001628280-24-034972.md) | [11.9](/filings/0001628280-24-046505.md) | [11.8](/filings/0001628280-26-011682.md) | [11.9](/filings/0001628280-25-023159.md) | [12.2](/filings/0001628280-25-038323.md) | [12.2](/filings/0001046102-25-000009.md) | [12.1](/filings/0001628280-26-052582.md) | [12.4](/filings/0001628280-26-029808.md) | [12.5](/filings/0001628280-26-052582.md) |
| Current liabilities | $bn | [1.4](/filings/0001628280-23-038257.md) | [1.3](/filings/0001628280-25-008201.md) | [1.5](/filings/0001628280-24-022241.md) | [1.5](/filings/0001628280-24-034972.md) | [1.4](/filings/0001628280-24-046505.md) | [1.3](/filings/0001628280-26-011682.md) | [1.4](/filings/0001628280-25-023159.md) | [1.5](/filings/0001628280-25-038323.md) | [1.5](/filings/0001046102-25-000009.md) | [1.6](/filings/0001628280-26-052582.md) | [1.8](/filings/0001628280-26-029808.md) | [1.4](/filings/0001628280-26-052582.md) |
| Total liabilities | $bn | [6.6](/filings/0001628280-23-038257.md) | [6.5](/filings/0001628280-25-008201.md) | [6.5](/filings/0001628280-24-022241.md) | [6.4](/filings/0001628280-24-034972.md) | [6.2](/filings/0001628280-24-046505.md) | [6.1](/filings/0001628280-26-011682.md) | [6.1](/filings/0001628280-25-023159.md) | [6.2](/filings/0001628280-25-038323.md) | [6.3](/filings/0001046102-25-000009.md) | [6.1](/filings/0001628280-26-052582.md) | [6.3](/filings/0001628280-26-029808.md) | [6.4](/filings/0001628280-26-052582.md) |
| Long-term debt | $bn | [3.1](/filings/0001628280-23-038257.md) | [3.1](/filings/0001628280-25-008201.md) | [2.9](/filings/0001628280-24-022241.md) | [2.8](/filings/0001628280-24-034972.md) | [2.7](/filings/0001628280-24-046505.md) | [2.6](/filings/0001628280-26-011682.md) | [2.6](/filings/0001628280-25-023159.md) | [2.5](/filings/0001628280-25-038323.md) | [2.5](/filings/0001046102-25-000009.md) | [2.3](/filings/0001628280-26-052582.md) | [2.3](/filings/0001628280-26-029808.md) | [2.8](/filings/0001628280-26-052582.md) |
| Current portion of debt | $bn | [0.0](/filings/0001628280-23-038257.md) | [0.0](/filings/0001628280-25-008201.md) | [0.0](/filings/0001628280-24-022241.md) | [0.0](/filings/0001628280-24-034972.md) | [0.0](/filings/0001628280-24-046505.md) | [0.0](/filings/0001628280-26-011682.md) | [0.0](/filings/0001628280-25-023159.md) | [0.1](/filings/0001628280-25-038323.md) | [0.1](/filings/0001046102-25-000009.md) | [0.1](/filings/0001628280-26-052582.md) | [0.1](/filings/0001628280-26-029808.md) | [0.1](/filings/0001628280-26-052582.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001628280-23-038257.md) | [0.0](/filings/0001628280-25-008201.md) | [0.0](/filings/0001628280-24-022241.md) | [0.0](/filings/0001628280-24-034972.md) | [0.0](/filings/0001628280-24-046505.md) | [0.0](/filings/0001628280-26-011682.md) | [0.1](/filings/0001628280-25-023159.md) | [0.1](/filings/0001628280-25-038323.md) | [0.1](/filings/0001046102-25-000009.md) | [0.1](/filings/0001628280-26-052582.md) | [0.3](/filings/0001628280-26-029808.md) | [0.0](/filings/0001628280-26-052582.md) |
| Shareholders' equity | $bn | [4.9](/filings/0001628280-23-038257.md) | [5.0](/filings/0001628280-25-008201.md) | [5.1](/filings/0001628280-24-022241.md) | [5.2](/filings/0001628280-24-034972.md) | [5.2](/filings/0001628280-24-046505.md) | [5.2](/filings/0001628280-26-011682.md) | [5.3](/filings/0001628280-25-023159.md) | [5.5](/filings/0001628280-25-038323.md) | [5.5](/filings/0001046102-25-000009.md) | [5.6](/filings/0001628280-26-052582.md) | [5.6](/filings/0001628280-26-029808.md) | [5.6](/filings/0001628280-26-052582.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [157 d](/filings/0001628280-24-046505.md) | [337 d](/filings/0001628280-26-011682.md) | [125](/filings/0001628280-25-023159.md) | [337 d](/filings/0001628280-25-038323.md) | [285 d](/filings/0001046102-25-000009.md) | [185 d](/filings/0001628280-26-011682.md) | [157](/filings/0001628280-26-029808.md) | [327 d](/filings/0001628280-26-052582.md) | [240 d](/filings/0001046102-25-000009.md) | [255 d](/filings/0001628280-26-011682.md) | [224](/filings/0001628280-26-029808.md) | [142 d](/filings/0001628280-26-052582.md) |
| Capital expenditure | $m | [61.4 d](/filings/0001628280-24-046505.md) | [74.3 d](/filings/0001628280-26-011682.md) | [45.2](/filings/0001628280-25-023159.md) | [28.7 d](/filings/0001628280-25-038323.md) | [36.9 d](/filings/0001046102-25-000009.md) | [56.6 d](/filings/0001628280-26-011682.md) | [54.3](/filings/0001628280-26-029808.md) | [84.8 d](/filings/0001628280-26-052582.md) | [51.2 d](/filings/0001046102-25-000009.md) | [68.7 d](/filings/0001628280-26-011682.md) | [51.5](/filings/0001628280-26-029808.md) | [78.1 d](/filings/0001628280-26-052582.md) |
| Dividends paid | $m | [49.2 d](/filings/0001628280-24-046505.md) | [49.3 d](/filings/0001628280-25-008201.md) | [49.3](/filings/0001628280-25-023159.md) | [49.6 d](/filings/0001628280-25-038323.md) | [53.5 d](/filings/0001046102-25-000009.md) | [53.6 d](/filings/0001628280-25-008201.md) | [53.5](/filings/0001628280-25-023159.md) | [53.8 d](/filings/0001628280-25-038323.md) | [58.2 d](/filings/0001046102-25-000009.md) | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [150](/filings/0001628280-26-052582.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [112](/filings/0001628280-23-038257.md) | [120](/filings/0001628280-24-022241.md) | [183](/filings/0001628280-24-034972.md) | [184](/filings/0001628280-24-046505.md) | [185](/filings/0001628280-25-023159.md) | [185](/filings/0001628280-25-038323.md) | [186](/filings/0001046102-25-000009.md) | [186](/filings/0001628280-26-029808.md) | [187](/filings/0001628280-26-052582.md) | [187](/filings/0001046102-25-000009.md) | [188](/filings/0001628280-26-029808.md) | [187](/filings/0001628280-26-052582.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 185,200,000 at 2026-07-28, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052582.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.